Sol-Gel Technologies Ltd. (NASDAQ: SLGL) Making Surprising Moves in Wednesday SessionSol-Gel Technologies Ltd. (
NASDAQ: SLGL) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 5.28% on the day to $3.99.
Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States
Sol-Gel Technologies, Ltd. (
NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology company, today announced they have signed two exclusive 5-year license agreements for the commercialization of EPSOLAY® and TWYNEO® in the United States.
